Research Article Details

Article ID: A12251
PMID: 30547370
Source: Pharmacoeconomics
Title: Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.
Abstract: Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.
DOI: 10.1007/s40273-018-0754-y